UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolomic analysis revealed mitochondrial dysfunction and aberrant choline metabolism in MPP+-exposed SH-SY5Y cells

Biochemical and biophysical research communications, 2019-11, Vol.519 (3), p.540-546

2019

Volltextzugriff (PDF)

Reply: PSAP variants in Parkinson's disease: a large cohort study in Chinese mainland population

Brain (London, England : 1878), 2021-04, Vol.144 (3), p.e26-e26

2021

Volltextzugriff (PDF)

A metabolic profile of polyamines in parkinson disease: A promising biomarker

Annals of neurology, 2019-08, Vol.86 (2), p.251-263

2019

Volltextzugriff (PDF)

Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease

Movement disorders, 2018-09, Vol.33 (9), p.1488-1492

2018

Volltextzugriff (PDF)

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease

Scientific reports, 2017-08, Vol.7 (1), p.7328-15, Article 7328

2017

Volltextzugriff (PDF)

Variants in saposin D domain of prosaposin gene linked to Parkinson's disease

Brain (London, England : 1878), 2020-04, Vol.143 (4), p.1190-1205

2020

Volltextzugriff (PDF)

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease

Stem cell reports, 2020-06, Vol.14 (6), p.1060-1075

2020

Volltextzugriff (PDF)

Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson’s disease in Japan

Scientific reports, 2023-03, Vol.13 (1), p.3600-3600, Article 3600

2023

Volltextzugriff (PDF)

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy

PloS one, 2019-09, Vol.14 (9), p.e0223113-e0223113

2019

Volltextzugriff (PDF)

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

Movement disorders, 2020-08, Vol.35 (8), p.1438-1447

2020

Volltextzugriff (PDF)

Metabolomic analysis data of MPP+-exposed SH-SY5Y cells using CE-TOFMS

Data in brief, 2021-02, Vol.34, p.106707-106707, Article 106707

2021

Volltextzugriff (PDF)

Factor analysis for construct validity of a trunk impairment scale in Parkinson's disease: a cross-sectional study

Frontiers in neurology, 2024-01, Vol.14, p.1303215-1303215

2024

Volltextzugriff (PDF)

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease

NPJ Parkinson's Disease, 2022-08, Vol.8 (1), p.97-97, Article 97

2022

Volltextzugriff (PDF)

Metabolomics‐based identification of metabolic alterations in PARK2

Annals of clinical and translational neurology, 2019-03, Vol.6 (3), p.525-536

2019

Volltextzugriff (PDF)

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease

Annals of clinical and translational neurology, 2020-03, Vol.7 (3), p.307-317

2020

Volltextzugriff (PDF)

Limb-Shaking Transient Ischemic Attack Induced by Middle Cerebral Artery Dissection after Lung Surgery

Journal of stroke and cerebrovascular diseases, 2017-10, Vol.26 (10), p.e197-e198

2017

Volltextzugriff (PDF)

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease

Journal of Parkinson's disease, 2021-01, Vol.11 (3), p.1221-1235

2021

Volltextzugriff (PDF)

Reversible Focal Cerebral Cortical Lesions in a Patient with Heat Stroke

Internal Medicine, 2013, Vol.52(3), pp.377-380

2013

Volltextzugriff (PDF)

Cerebral Infarction in a Case of Parry-Romberg Syndrome

Journal of stroke and cerebrovascular diseases, 2014-02, Vol.23 (2), p.393-394

2014

Volltextzugriff (PDF)

Spontaneous spinal subarachnoid hemorrhage after severe coughing: a case report

Journal of medical case reports, 2013-12, Vol.7 (1), p.274-274, Article 274

2013

Volltextzugriff (PDF)

Reply: PSAP intronic variants around saposin D domain and Parkinson's disease

Brain (London, England : 1878), 2021-02, Vol.144 (1), p.e4-e4

2021

Volltextzugriff (PDF)

Reply: Association analysis of PSAP variants in Parkinson's disease patients

Brain (London, England : 1878), 2021-02, Vol.144 (1), p.e10-e10

2021

Volltextzugriff (PDF)

Reply: Saposin D variants are not a common cause of familial Parkinson's disease among Italians; and Lack of evidence for genetic association of saposins A, B, C and D with Parkinson's disease

Brain (London, England : 1878), 2020-09, Vol.143 (9), p.e73-e73

2020

Volltextzugriff (PDF)

Midbrain atrophy in pathologically diagnosed Lewy body disease and clinically diagnosed Parkinson's disease

Journal of the neurological sciences, 2023-11, Vol.454, p.120821-120821, Article 120821

2023

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metabolomic analysis revealed mitochondrial dysfunction and aberrant choline metabolism in MPP+-exposed SH-SY5Y cells

Reply: PSAP variants in Parkinson's disease: a large cohort study in Chinese mainland population

A metabolic profile of polyamines in parkinson disease: A promising biomarker

Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease

Variants in saposin D domain of prosaposin gene linked to Parkinson's disease

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease

Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson’s disease in Japan

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

Metabolomic analysis data of MPP+-exposed SH-SY5Y cells using CE-TOFMS

Factor analysis for construct validity of a trunk impairment scale in Parkinson's disease: a cross-sectional study

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD)

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease

Metabolomics‐based identification of metabolic alterations in PARK2

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease

Limb-Shaking Transient Ischemic Attack Induced by Middle Cerebral Artery Dissection after Lung Surgery

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease

Reversible Focal Cerebral Cortical Lesions in a Patient with Heat Stroke

Cerebral Infarction in a Case of Parry-Romberg Syndrome

Spontaneous spinal subarachnoid hemorrhage after severe coughing: a case report

Reply: PSAP intronic variants around saposin D domain and Parkinson's disease

Reply: Association analysis of PSAP variants in Parkinson's disease patients

Reply: Saposin D variants are not a common cause of familial Parkinson's disease among Italians; and Lack of evidence for genetic association of saposins A, B, C and D with Parkinson's disease

Midbrain atrophy in pathologically diagnosed Lewy body disease and clinically diagnosed Parkinson's disease

Suchergebnisse filtern